Next Pharmaceuticals Announces A New Clinical Study Demonstrating Relora(R) Significantly Relieves Short-Term Anxiety In Healthy Women
May 15th 2008Drug InformationAnxiety
Next Pharmaceuticals announced the results of a six-week, double-blind, placebo-controlled clinical study on Relora conducted on healthy women between the ages of 20 and 50. Relora significantly reduced short-term anxiety compared to the placebo group. The study conducted by Miami Research Associates, a clinical research organization in Miami, Florida, was published in Nutrition Journal, an open access peer-reviewed, online journal.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
